The FDA just approved a treatment for pancreatic cancer that could extend patient lives by years. Yet the annual cost sits at $475,000, a price tag deemed ludicrously high and out of reach for those lacking solid insurance coverage.
3w
The FDA just approved a treatment for pancreatic cancer that could extend patient lives by years. Yet the annual cost sits at $475,000, a price tag deemed ludicrously high and out of reach for those lacking solid insurance coverage.
3w
لا توجد تعليقات بعد. كن أول من يعلّق!
التعليقات
لا توجد تعليقات بعد. كن أول من يعلّق!